IP Library Patent Application 11032558
Patent Application
App. No. 11/032,558

Cell culture media

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/032,558
Abstract

The invention is a cell culture medium that can include reduced or no serum and that enhances the performance of serum-free media for cell culture. The medium supports the growth of cells for both small scale and large scale propagation of cells. The invention also includes a method of cultivating cells using the cell culture medium of the present invention.

Claims (21)

1 . A cell culture media comprising the following components: basal media, approximately 1-4 mM glutamine, approximately 0.3-2% albumin, approximately 5-15 mg/L insulin, approximately 0.5-9 mg/L transferrin, approximately 5-15 uM ethanolamine, and approximately 1-3% of a purified lipoprotein material.

2 . A cell culture media comprising the following components: basal media, sodium selenite, albumin, insulin, transferrin, peptone, fetuin, vitamin E and a purified lipoprotein material.

3 . The cell culture media of claim 1 or 2 wherein the purified lipoprotein material is derived from bovine serum or plasma.

4 . The cell culture media of claim 1 or 2 wherein the purified lipoprotein material is cholesterol-rich.

5 . The cell culture media of claim 1 or 2 wherein the purified lipoprotein material is produced by contacting serum or plasma with a silica adsorbant.

6 . A method to culture cells comprising incubating the cells in a culture media consisting essentially of the following components: basal media, glutamine, albumin, insulin, transferrin, ethanolamine, and a purified lipoprotein material.

7 . A method to culture cells comprising incubating the cells in a culture media comprising the following components: basal media, sodium selenite, albumin, insulin, transferrin, peptone, fetuin, vitamin E and a purified lipoprotein material.

8 . The method of claim 6 or 7 wherein the purified lipoprotein material is derived from bovine serum or plasma.

9 . The method of claim 6 or 7 wherein the purified lipoprotein material is cholesterol-rich.

10 . The method of claim 6 or 7 wherein the purified lipoprotein material is produced by contacting serum or plasma with a silica adsorbant.

11 . The method of claim 6 wherein the cells produce a peptide.

12 . The method of claim 11 wherein the peptide is an antibody.

13 . The method of claim 11 wherein the peptide is an immunoglobulin.

14 . The method of claim 6 wherein the cells are hybridoma cells.

15 . The method of claim 7 wherein the cells are cancer cells.

16 . The method of claim 7 wherein the cells are in suspension.

17 . The method of claim 7 wherein the cells are adherent.

18 . The method of claim 7 , wherein the cells are selected from the group consisting of K562 cells, HL-60 cells, Daudi cells, HeLA cells, THP-1 cells, Jurkat cells and EL4 cells.

19 . The method of claim 7 wherein the cells are human cells.

20 . A method for culturing hybridoma cells in vitro comprising incubating the cells in a cell culture media comprising the following components: basal media, glutamine, albumin, insulin, transferrin, ethanolamine, and a purified lipoprotein material.

21 . A cell culture media consisting essentially of the following components: basal media, glutamine, albumin, insulin, transferrin, ethanolamine, and a purified lipoprotein material.

Assignments (7)
CHANGE OF NAME Recorded Jan 31, 2012
From: MILLIPORE CORPORATION
To: EMD MILLIPORE CORPORATION
Reel/Frame 027620/0891 →
MERGER Recorded Apr 8, 2008
From: SEROLOGICALS FINANCE COMPANY
To: SEROLOGICALS CORPORATION
Reel/Frame 020762/0587 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ALL PATENTS LISTED PREVIOUSLY RECORDED ON REEL 019220 FRAME 0389. ASSIGNOR(S) HEREBY CONFIRMS THE SEROLOGICALS ROYALTY COMPANY MERGER THROUGH TO MILLIPORE CORPORATION. Recorded Apr 8, 2008
From: SEROLOGICALS ROYALTY COMPANY
To: SEROLOGICALS FINANCE COMPANY
Reel/Frame 020762/0592 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ALL OF IT - CLIENT WISHES TO RECORD EACH MERGER SEPARATELY. PREVIOUSLY RECORDED ON REEL 019220 FRAME 0355. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER FROM SEROLOGICALS INVESTMENT COMPANY TO FINAL OWNER MILLIPORE CORPORATION.. Recorded Apr 8, 2008
From: SEROLOGICALS INVESTMENT COMPANY
To: SEROLOGICALS ROYALTY COMPANY
Reel/Frame 020762/0580 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ALL PATENTS LISTED PREVIOUSLY RECORDED ON REEL 019220 FRAME 0389. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER FROM SEROLOGICALS ROYALTY COMPANY THROUGH TO MILLIPORE CORPORATION. Recorded Apr 8, 2008
From: SEROLOGICALS CORPORATION
To: MILLIPORE CORPORATION
Reel/Frame 020762/0599 →
MERGER Recorded Apr 27, 2007
From: SEROLOGICALS ROYALTY COMPANY; SEROLOGICALS FINANCE COMPANY; SEROLOGICALS CORPORATION
To: SEROLOGICALS FINANCE COMPANY; SEROLOGICALS CORPORATION; MILLIPORE CORPORATION
Reel/Frame 019220/0389 →
MERGER Recorded Apr 27, 2007
From: SEROLOGICALS INVESTMENT COMPANY
To: SEROLOGICALS ROYALTY COMPANY
Reel/Frame 019220/0355 →